← BRISTOL MYERS SQUIBB CO

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings/(loss) $4.5b $975.0m $4.9b $3.5b ($9.0b) $7.0b $6.3b $8.0b ($8.9b) $7.1b —
Net Income (Loss) Attributable to Parent $4.5b
$1.0b -77.41%
$4.9b +388.58%
$3.4b -30.10%
($9.0b) -362.14%
$7.0b +177.58%
$6.3b -9.54%
$8.0b +26.84%
($8.9b) -211.50%
$7.1b +178.83%
—
Net Income (Loss) Attributable to Noncontrolling Interest $50.0m ($32.0m) $27.0m $21.0m $20.0m $20.0m $18.0m — — — —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $4.5b $975.0m $4.9b $3.5b ($9.0b) $7.0b $6.3b $8.0b ($8.9b) $7.1b —
Amortization of Intangible Assets $178.0m $190.0m $198.0m $1.3b $9.9b $10.2b $9.7b $9.2b $9.0b $3.5b —
Depreciation $448.0m $682.0m $505.0m $554.0m $586.0m $559.0m $587.0m $611.0m $651.0m $621.0m $3.2b
Depreciation and amortization, net $382.0m $789.0m $637.0m $1.7b $10.4b $10.7b $10.3b $9.8b $9.6b $4.0b $3.2b
Depreciation, Depletion and Amortization $382.0m $789.0m $637.0m $1.7b $10.4b $10.7b $10.3b $9.8b $9.6b $4.0b $3.2b
Deferred Income Tax Expense (Benefit) ($204.0m) $1.0b $86.0m ($924.0m) $983.0m ($1.4b) ($2.7b) ($3.3b) ($2.1b) ($965.0m) ($785.0m)
Share-based Payment Arrangement, Expense $205.0m $199.0m $221.0m $441.0m $779.0m $583.0m $457.0m $518.0m $507.0m $553.0m $553.0m
Share-based Payment Arrangement, Noncash Expense $205.0m $199.0m $221.0m $441.0m $779.0m $583.0m $457.0m $518.0m $507.0m $553.0m $553.0m
Stock-based compensation $205.0m $199.0m $221.0m $441.0m $779.0m $583.0m $457.0m $518.0m $507.0m $553.0m $553.0m
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount — — — — ($204.0m) — — — — — —
Impairment charges $108.0m $332.0m $126.0m $199.0m $1.2b $1.2b $179.0m $255.0m $3.0b $1.1b —
Impairment of Intangible Assets (Excluding Goodwill) $33.0m $80.0m $84.0m $66.0m $1.1b $1.2b $101.0m $136.0m $2.9b $949.0m —
Impairment of Intangible Assets, Finite-lived $15.0m — $64.0m $15.0m $21.0m $0 — — — — —
Operating Lease, Impairment Loss — — — — $31.0m — — $85.0m — — —
Restructuring Costs and Asset Impairment Charges $213.0m $826.0m $268.0m — $1.4b $751.0m $520.0m $777.0m $1.1b $926.0m —
Equity Method Investment, Realized Gain (Loss) on Disposal — — — — — $745.0m ($801.0m) ($160.0m) $16.0m $280.0m —
Equity investment (gains)/losses, net — — — ($275.0m) ($1.2b) ($745.0m) $801.0m $160.0m ($16.0m) ($280.0m) —
Income (Loss) from Equity Method Investments $77.0m $75.0m $93.0m ($4.0m) — $231.0m ($108.0m) ($38.0m) $44.0m $47.0m —
Other Nonoperating Income (Expense) $1.3b $1.5b $850.0m ($938.0m) $2.3b $720.0m ($576.0m) $1.2b ($893.0m) ($674.0m) —
Proceeds from sales of equity investments — — — — — $2.6b $218.0m $215.0m $265.0m $77.0m —
Changes in operating assets and liabilities:
Receivables ($803.0m) ($431.0m) ($429.0m) $752.0m ($646.0m) ($1.1b) ($663.0m) ($995.0m) $264.0m ($295.0m) $678.0m
Increase (Decrease) in Inventories $152.0m $29.0m $216.0m ($463.0m) ($2.7b) ($13.0m) $69.0m $751.0m $486.0m $184.0m ($41.0m)
Inventories ($152.0m) ($29.0m) ($216.0m) $463.0m $2.7b $13.0m ($69.0m) ($751.0m) ($486.0m) ($184.0m) ($41.0m)
Accounts payable $104.0m $320.0m ($59.0m) $229.0m $188.0m $245.0m $109.0m $198.0m $184.0m ($2.0m) $450.0m
Other $100.0m ($22.0m) ($54.0m) ($53.0m) $542.0m $641.0m ($610.0m) ($667.0m) $624.0m $471.0m —
Net Cash Provided by (Used in) Operating Activities $2.9b
$5.3b +85.09%
$5.9b +12.61%
$8.1b +35.81%
$14.1b +74.19%
$16.2b +15.34%
$13.1b -19.38%
$13.9b +6.08%
$15.2b +9.60%
$14.2b -6.81%
$12.8b -9.71%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $1.2b $1.1b $951.0m $836.0m $753.0m $973.0m $1.1b $1.2b $1.2b $1.3b ($1.3b)
Gain (Loss) on Investments — — — — — — ($801.0m) ($160.0m) $16.0m $280.0m —
Purchase of marketable debt securities ($3.1b) ($5.4b) ($2.3b) ($4.0b) ($4.2b) ($5.5b) ($3.6b) ($1.8b) ($769.0m) ($2.0b) —
Sale and maturities of marketable debt securities $4.8b $6.4b $2.4b $3.8b $6.3b $4.2b $6.4b $733.0m $1.1b $2.0b —
Unrealized Gain (Loss) on Investments — — — — $1.2b ($760.0m) ($779.0m) ($120.0m) ($9.0m) $287.0m —
Divestiture and other proceeds $1.3b $722.0m $1.2b $15.9b $870.0m $748.0m $1.3b $909.0m $1.1b $1.1b —
Divestiture gains and royalties ($1.2b) ($706.0m) ($992.0m) ($1.9b) ($699.0m) ($684.0m) ($1.1b) ($884.0m) ($1.1b) ($1.2b) —
Payments to Acquire Businesses, Net of Cash Acquired $359.0m $708.0m $1.2b $24.6b $13.1b $1.6b $4.3b $1.2b $21.8b $3.9b ($3.7b)
Net Cash Provided by (Used in) Investing Activities $1.5b ($66.0m) ($874.0m) ($9.8b) ($10.9b) ($538.0m) ($1.1b) ($2.3b) ($21.4b) ($4.1b) ($4.9b)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt — ($109.0m) $0 $0 — ($281.0m) ($266.0m) $0 $0 ($356.0m) —
Proceeds from Issuance of Long-term Debt $2.4b $1.5b $0 $26.8b $6.9b $0 $5.9b $4.5b $12.9b $5.7b $0
Proceeds from issuance of short-term debt obligations — — — — — — $0 $0 $3.0b $0 —
Repayments of Long-term Debt $15.0m $1.2b $5.0m $9.3b $2.8b $6.0b $11.4b $3.9b $2.9b $10.9b ($12.0b)
Repayments of short-term debt obligations — — — — — — $0 $0 ($3.0b) $0 —
Payments for Repurchase of Common Stock $231.0m $2.5b $320.0m $7.3b $1.5b $6.3b $8.0b $5.2b $0 $0 —
Repurchase of common stock ($231.0m) ($2.5b) ($320.0m) ($7.3b) ($1.5b) ($6.3b) ($8.0b) ($5.2b) $0 $0 —
Dividends ($3k) ($3k) ($3k) ($3k) ($4k) ($4k) ($5k) ($5k) ($5k) ($5k) ($5.1b)
Dividends Payable, Current $660.0m $654.0m $669.0m $1.0b $1.1b $1.2b $1.2b $1.2b $1.3b $1.3b —
Dividends paid $2.5b $2.6b $2.6b $2.7b $4.1b $4.4b $4.6b $4.7b $4.9b $5.0b ($5.1b)
Other short-term financing obligations, net — — — — — — $194.0m ($120.0m) $99.0m $25.0m —
Proceeds from (Payments for) Other Financing Activities — ($22.0m) ($54.0m) ($53.0m) $542.0m $641.0m $984.0m $27.0m — — —
Net Cash Provided by (Used in) Financing Activities ($2.4b)
($4.1b) -66.75%
($3.5b) +13.29%
$7.6b +315.59%
($1.2b) -115.10%
($16.2b) -1309.56%
($17.0b) -4.55%
($9.4b) +44.49%
$5.1b +154.45%
($10.3b) -301.83%
($11.7b) -13.15%
Increase/(decrease) in cash, cash equivalents and restricted cash — $1.2b $1.5b $5.9b $2.2b ($657.0m) ($5.0b) $2.2b ($1.2b) ($129.0m) —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — $52.0m ($41.0m) $5.9b $2.2b ($657.0m) ($5.0b) $2.2b ($1.2b) ($129.0m) $8.8b
Cash, cash equivalents and restricted cash at beginning of period — $5.4b $6.9b $12.8b $15.0b $14.3b $9.3b $11.5b $10.3b $10.2b —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — $52.0m ($41.0m) $12.8b $15.0b $14.3b $9.3b $11.5b $10.3b $10.2b $8.8b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — $52.0m ($41.0m) ($9.0m) $111.0m ($102.0m) ($33.0m) $45.0m ($137.0m) $195.0m ($57.0m)
Effect of exchange rates on cash, cash equivalents and restricted cash — $52.0m ($41.0m) ($9.0m) $111.0m ($102.0m) ($33.0m) $45.0m ($137.0m) $195.0m —
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Acquired IPRD — — — — $12.5b $1.2b $815.0m $913.0m $13.4b $3.7b —
Acquisition and other payments, net of cash acquired ($359.0m) ($708.0m) ($1.2b) ($24.6b) ($13.1b) ($1.6b) ($4.3b) ($1.2b) ($21.8b) ($3.9b) —
Additional Financial Items
Contingent consideration fair value adjustments — $0 $0 $523.0m ($1.8b) ($542.0m) ($9.0m) ($8.0m) $0 $351.0m —
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — — — — — — — — ($119.0m) — —
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $564.0m $161.0m $178.0m $1.2b $55.0m $9.0m $211.0m $0 ($15.0m) ($1.0m) —
Equity Securities, FV-NI, Gain (Loss) — — ($530.0m) $170.0m — — — — — — —
Equity Securities, FV-NI, Realized Gain (Loss) — — $7.0m $14.0m ($12.0m) $357.0m $17.0m $3.0m ($32.0m) $4.0m —
Equity Securities, FV-NI, Unrealized Gain (Loss) — — ($537.0m) $156.0m $1.2b ($403.0m) ($762.0m) ($117.0m) ($41.0m) $291.0m —
Foreign Currency Transaction Gain (Loss), Realized $52.0m — — — — — — — — — —
Gain (Loss) Related to Litigation Settlement ($47.0m) $487.0m ($76.0m) ($77.0m) $194.0m ($82.0m) ($178.0m) $390.0m ($84.0m) ($434.0m) —
Goodwill $6.9b $6.9b $6.5b $22.5b $20.5b $20.5b $21.1b $21.2b $21.7b $21.8b $1.6b
Income Tax Expense (Benefit) $1.4b $4.2b $1.0b $1.5b $2.1b $1.1b $1.4b $400.0m $554.0m $2.3b —
Income Taxes Paid, Net $2.0b $546.0m $747.0m $1.5b $3.4b $3.5b $5.4b $4.3b $3.9b $3.3b —
Income taxes payable ($545.0m) $2.6b $162.0m $907.0m ($2.3b) ($1.1b) ($1.4b) ($603.0m) ($1.3b) ($4.0m) —
Interest Expense Nonoperating — — — — — — — — $1.9b $1.9b —
Interest Paid, Excluding Capitalized Interest, Operating Activities $191.0m $215.0m $212.0m $414.0m $1.6b $1.5b $1.4b $1.2b $1.8b $2.1b —
Investment Income, Interest $105.0m $154.0m $173.0m $464.0m $121.0m $39.0m $171.0m $449.0m $478.0m $586.0m —
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($9.0m) ($11.0m) — — — — — — — — —
Other adjustments ($44.0m) $92.0m ($44.0m) ($22.0m) ($177.0m) $142.0m $232.0m $308.0m $94.0m $232.0m —
Rebates and discounts — — — $591.0m $1.2b $863.0m $427.0m $904.0m $1.5b ($441.0m) —
Stock option proceeds and other, net — — — — $542.0m $641.0m $984.0m $27.0m ($106.0m) ($128.0m) —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.